{
  "id": 6310347,
  "title": "Pharvaris' stock jumps on pivotal success in rare genetic disease",
  "url": "https://urgent.news/2026/09/08/pharvaris-stock-jumps-on-pivotal-success-in-rare-genetic-disease",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-08T18:29:02.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/pharvaris-stock-jumps-on-pivotal-success-in-rare-genetic-disease/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Pharvaris claims it achieved “injectable-like efficacy” in a once-daily pill for a debilitating genetic disease. The experimental drug, an extended-release version of deucrictibant, is designed to prevent swelling attacks in patients with a rare disease ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}